Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Testosterone | 123 | 2024 | 2401 | 21.110 |
Why?
|
Hypogonadism | 47 | 2021 | 798 | 7.730 |
Why?
|
Hormone Replacement Therapy | 37 | 2021 | 744 | 6.720 |
Why?
|
Androgens | 34 | 2020 | 1271 | 5.850 |
Why?
|
Prostatic Neoplasms | 68 | 2021 | 11039 | 4.090 |
Why?
|
Erectile Dysfunction | 25 | 2017 | 459 | 3.540 |
Why?
|
Prostate-Specific Antigen | 23 | 2019 | 2458 | 2.210 |
Why?
|
Andropause | 4 | 2014 | 8 | 1.960 |
Why?
|
5-alpha Reductase Inhibitors | 4 | 2018 | 106 | 1.820 |
Why?
|
Testis | 9 | 2024 | 800 | 1.640 |
Why?
|
Sexual Dysfunction, Physiological | 5 | 2019 | 357 | 1.410 |
Why?
|
Azasteroids | 3 | 2014 | 37 | 1.200 |
Why?
|
Sexual Dysfunctions, Psychological | 5 | 2021 | 187 | 1.050 |
Why?
|
Finasteride | 2 | 2018 | 89 | 1.040 |
Why?
|
Orchiectomy | 6 | 2024 | 466 | 1.030 |
Why?
|
Penile Prosthesis | 9 | 2007 | 38 | 1.020 |
Why?
|
Male | 178 | 2024 | 349538 | 1.010 |
Why?
|
Prostate | 12 | 2014 | 1764 | 1.010 |
Why?
|
Infertility, Male | 5 | 2013 | 407 | 0.930 |
Why?
|
Lizards | 3 | 2021 | 55 | 0.870 |
Why?
|
Prostatectomy | 11 | 2019 | 1871 | 0.840 |
Why?
|
Radioimmunoassay | 3 | 2013 | 918 | 0.840 |
Why?
|
Spermatogenesis | 6 | 2008 | 262 | 0.840 |
Why?
|
Deficiency Diseases | 4 | 2017 | 72 | 0.770 |
Why?
|
Urology | 3 | 2019 | 397 | 0.770 |
Why?
|
Estrogens | 3 | 2013 | 1562 | 0.750 |
Why?
|
Libido | 7 | 2021 | 121 | 0.740 |
Why?
|
Cardiovascular System | 3 | 2019 | 827 | 0.740 |
Why?
|
Men's Health | 2 | 2017 | 73 | 0.710 |
Why?
|
Dihydrotestosterone | 5 | 2014 | 188 | 0.690 |
Why?
|
Myocardial Infarction | 7 | 2015 | 11690 | 0.680 |
Why?
|
Luteinizing Hormone | 3 | 2019 | 864 | 0.670 |
Why?
|
Eunuchism | 1 | 2018 | 19 | 0.660 |
Why?
|
Penile Erection | 8 | 2017 | 97 | 0.630 |
Why?
|
Humans | 172 | 2024 | 742088 | 0.630 |
Why?
|
Nerve Growth Factor | 1 | 2018 | 149 | 0.610 |
Why?
|
Andrology | 1 | 2017 | 10 | 0.590 |
Why?
|
Hysteria | 1 | 2016 | 22 | 0.590 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2017 | 548 | 0.590 |
Why?
|
Prostatic Hyperplasia | 5 | 2019 | 522 | 0.590 |
Why?
|
Prescription Drugs | 2 | 2014 | 595 | 0.580 |
Why?
|
Spermatozoa | 6 | 2008 | 625 | 0.540 |
Why?
|
Sexuality | 2 | 2017 | 174 | 0.500 |
Why?
|
Stroke | 5 | 2014 | 9963 | 0.490 |
Why?
|
Testosterone Congeners | 2 | 2019 | 62 | 0.490 |
Why?
|
Nitriles | 2 | 2013 | 952 | 0.490 |
Why?
|
Aromatase Inhibitors | 3 | 2013 | 491 | 0.480 |
Why?
|
Dialysis | 1 | 2013 | 75 | 0.480 |
Why?
|
Cardiovascular Diseases | 14 | 2019 | 15108 | 0.480 |
Why?
|
Sexual Behavior | 6 | 2024 | 2050 | 0.470 |
Why?
|
Clomiphene | 1 | 2013 | 72 | 0.470 |
Why?
|
Triazoles | 2 | 2013 | 907 | 0.470 |
Why?
|
Mass Media | 1 | 2016 | 303 | 0.470 |
Why?
|
Neoplasms, Hormone-Dependent | 2 | 2012 | 414 | 0.460 |
Why?
|
Androstenedione | 1 | 2013 | 131 | 0.460 |
Why?
|
Estrogen Antagonists | 1 | 2013 | 151 | 0.450 |
Why?
|
Cryptorchidism | 5 | 2002 | 123 | 0.440 |
Why?
|
Phosphodiesterase Inhibitors | 4 | 2007 | 215 | 0.430 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.430 |
Why?
|
Periodicals as Topic | 2 | 2016 | 1431 | 0.420 |
Why?
|
Penis | 3 | 2014 | 216 | 0.420 |
Why?
|
Receptors, Androgen | 3 | 2014 | 1057 | 0.420 |
Why?
|
Oligospermia | 3 | 2006 | 59 | 0.410 |
Why?
|
Practice Guidelines as Topic | 11 | 2017 | 7276 | 0.410 |
Why?
|
Disease Progression | 9 | 2017 | 13256 | 0.400 |
Why?
|
Watchful Waiting | 1 | 2016 | 491 | 0.400 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2002 | 2948 | 0.390 |
Why?
|
Middle Aged | 61 | 2019 | 213127 | 0.390 |
Why?
|
Epididymis | 3 | 1998 | 227 | 0.390 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2017 | 1185 | 0.380 |
Why?
|
Transsexualism | 1 | 2013 | 177 | 0.370 |
Why?
|
Computers, Analog | 1 | 2009 | 6 | 0.360 |
Why?
|
Acid Phosphatase | 1 | 2010 | 141 | 0.360 |
Why?
|
Androgen-Binding Protein | 1 | 2009 | 10 | 0.360 |
Why?
|
Penile Induration | 1 | 2009 | 16 | 0.340 |
Why?
|
Circadian Rhythm | 2 | 2019 | 2623 | 0.340 |
Why?
|
Aged | 49 | 2021 | 162944 | 0.330 |
Why?
|
Interpersonal Relations | 1 | 2016 | 1423 | 0.320 |
Why?
|
Vas Deferens | 2 | 1998 | 55 | 0.310 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2007 | 21 | 0.310 |
Why?
|
Spermatic Cord | 1 | 2006 | 25 | 0.290 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 865 | 0.280 |
Why?
|
Brachytherapy | 1 | 2014 | 1246 | 0.280 |
Why?
|
Varicocele | 1 | 2006 | 78 | 0.270 |
Why?
|
Bibliometrics | 1 | 2009 | 339 | 0.270 |
Why?
|
Risk Factors | 24 | 2018 | 72145 | 0.270 |
Why?
|
Orgasm | 3 | 2017 | 64 | 0.260 |
Why?
|
Penile Diseases | 2 | 1996 | 46 | 0.260 |
Why?
|
Kallikreins | 2 | 2017 | 258 | 0.260 |
Why?
|
Chromosomes, Human, Y | 1 | 2006 | 148 | 0.260 |
Why?
|
Adult | 42 | 2019 | 213712 | 0.260 |
Why?
|
Carbolines | 1 | 2006 | 265 | 0.240 |
Why?
|
Vasodilator Agents | 2 | 2006 | 976 | 0.240 |
Why?
|
Science | 1 | 2007 | 241 | 0.240 |
Why?
|
History, 20th Century | 4 | 2018 | 2739 | 0.240 |
Why?
|
Organ Size | 6 | 2014 | 2253 | 0.240 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1509 | 0.230 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2003 | 76 | 0.230 |
Why?
|
Germ Cells | 2 | 1998 | 628 | 0.230 |
Why?
|
Apoptosis | 5 | 2002 | 9715 | 0.230 |
Why?
|
Gynecomastia | 1 | 2004 | 88 | 0.230 |
Why?
|
Population Surveillance | 1 | 2014 | 2616 | 0.230 |
Why?
|
Culture | 1 | 2007 | 632 | 0.220 |
Why?
|
Laboratories | 1 | 2006 | 461 | 0.220 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2003 | 238 | 0.220 |
Why?
|
Dehydroepiandrosterone | 1 | 2003 | 252 | 0.220 |
Why?
|
Prejudice | 1 | 2007 | 569 | 0.210 |
Why?
|
Aging | 4 | 2021 | 8626 | 0.210 |
Why?
|
Pituitary Diseases | 1 | 2003 | 141 | 0.210 |
Why?
|
Body Composition | 1 | 2011 | 2400 | 0.210 |
Why?
|
Retrospective Studies | 22 | 2017 | 77098 | 0.210 |
Why?
|
Prolactin | 1 | 2003 | 669 | 0.200 |
Why?
|
Testicular Neoplasms | 3 | 1994 | 761 | 0.200 |
Why?
|
Chromosome Deletion | 1 | 2006 | 1400 | 0.190 |
Why?
|
Clinical Trials as Topic | 5 | 2019 | 7901 | 0.190 |
Why?
|
Biomedical Research | 1 | 2016 | 3306 | 0.190 |
Why?
|
Bone Density | 1 | 2013 | 3469 | 0.190 |
Why?
|
Endocrinology | 1 | 2007 | 443 | 0.190 |
Why?
|
Pituitary Gland | 1 | 2003 | 665 | 0.190 |
Why?
|
Biological Assay | 2 | 2018 | 652 | 0.190 |
Why?
|
Gels | 2 | 2014 | 427 | 0.180 |
Why?
|
Seminal Vesicles | 2 | 1997 | 101 | 0.180 |
Why?
|
Palliative Care | 2 | 2005 | 3478 | 0.180 |
Why?
|
Patient Satisfaction | 4 | 2007 | 3391 | 0.170 |
Why?
|
Patient Compliance | 1 | 2010 | 2680 | 0.170 |
Why?
|
Lithotripsy | 2 | 1990 | 143 | 0.170 |
Why?
|
Risk | 4 | 2016 | 9679 | 0.170 |
Why?
|
Age Factors | 6 | 2017 | 18355 | 0.170 |
Why?
|
Diverticulum | 2 | 1997 | 136 | 0.160 |
Why?
|
History, 21st Century | 2 | 2018 | 1533 | 0.160 |
Why?
|
Body Temperature | 2 | 1999 | 776 | 0.160 |
Why?
|
Mass Screening | 4 | 2010 | 5238 | 0.160 |
Why?
|
China | 1 | 2024 | 2246 | 0.160 |
Why?
|
Biopsy | 5 | 2009 | 6756 | 0.150 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 2795 | 0.150 |
Why?
|
Teratoma | 2 | 1992 | 387 | 0.150 |
Why?
|
Animals | 20 | 2024 | 168561 | 0.150 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2522 | 0.150 |
Why?
|
United States | 13 | 2018 | 69693 | 0.150 |
Why?
|
Calcinosis | 1 | 2006 | 1497 | 0.150 |
Why?
|
Postoperative Complications | 6 | 2017 | 15244 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9185 | 0.140 |
Why?
|
Reproductive Techniques | 1 | 1996 | 42 | 0.140 |
Why?
|
Gonadotropins | 1 | 1997 | 241 | 0.140 |
Why?
|
Prosthesis Failure | 2 | 2001 | 1203 | 0.140 |
Why?
|
Treatment Outcome | 11 | 2018 | 62966 | 0.140 |
Why?
|
Aged, 80 and over | 12 | 2014 | 57683 | 0.140 |
Why?
|
Ureteral Diseases | 1 | 1996 | 61 | 0.140 |
Why?
|
Reference Values | 2 | 2017 | 4982 | 0.140 |
Why?
|
Journalism, Medical | 1 | 2016 | 74 | 0.140 |
Why?
|
Nuclear Envelope | 1 | 1997 | 172 | 0.140 |
Why?
|
Czech Republic | 1 | 2015 | 69 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2013 | 2372 | 0.140 |
Why?
|
Drug Monitoring | 3 | 2015 | 956 | 0.130 |
Why?
|
Piperazines | 2 | 2004 | 2488 | 0.130 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 170 | 0.130 |
Why?
|
Bioethical Issues | 1 | 2016 | 124 | 0.130 |
Why?
|
Bone Diseases | 1 | 2019 | 416 | 0.130 |
Why?
|
Mycobacterium Infections | 1 | 1996 | 119 | 0.130 |
Why?
|
Mexico | 1 | 2017 | 688 | 0.130 |
Why?
|
Drug Implants | 3 | 2012 | 243 | 0.130 |
Why?
|
Spinal Cord Compression | 1 | 2017 | 235 | 0.130 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 1992 | 279 | 0.130 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.130 |
Why?
|
Peripheral Vascular Diseases | 1 | 2018 | 550 | 0.130 |
Why?
|
Hot Temperature | 2 | 1998 | 1355 | 0.120 |
Why?
|
Time Factors | 6 | 2017 | 40054 | 0.120 |
Why?
|
Medical Audit | 1 | 2016 | 467 | 0.120 |
Why?
|
Risk Assessment | 6 | 2017 | 23320 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 977 | 0.120 |
Why?
|
Heterosexuality | 1 | 2016 | 271 | 0.120 |
Why?
|
Weights and Measures | 1 | 2013 | 43 | 0.120 |
Why?
|
Neurosurgical Procedures | 1 | 2005 | 2002 | 0.120 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4839 | 0.120 |
Why?
|
United States Food and Drug Administration | 2 | 2018 | 1581 | 0.120 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 1993 | 80 | 0.120 |
Why?
|
Immunoassay | 1 | 2017 | 752 | 0.110 |
Why?
|
Vasectomy | 1 | 1993 | 52 | 0.110 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6347 | 0.110 |
Why?
|
Sex Reassignment Procedures | 1 | 2013 | 50 | 0.110 |
Why?
|
Prosthesis Design | 5 | 2007 | 2110 | 0.110 |
Why?
|
Long-Term Care | 2 | 2010 | 607 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2021 | 1350 | 0.110 |
Why?
|
Dysgerminoma | 1 | 1992 | 52 | 0.110 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3800 | 0.110 |
Why?
|
Running | 1 | 1997 | 478 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 1994 | 300 | 0.110 |
Why?
|
Severity of Illness Index | 5 | 2009 | 15530 | 0.110 |
Why?
|
Estrogen Receptor Modulators | 1 | 2012 | 61 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 654 | 0.100 |
Why?
|
Temperature | 2 | 1997 | 2207 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1548 | 0.100 |
Why?
|
Canada | 1 | 2017 | 2061 | 0.100 |
Why?
|
Infusions, Subcutaneous | 1 | 2011 | 42 | 0.100 |
Why?
|
Expert Testimony | 1 | 2014 | 356 | 0.100 |
Why?
|
Sexual Partners | 1 | 2016 | 730 | 0.100 |
Why?
|
Quality of Life | 5 | 2021 | 12730 | 0.100 |
Why?
|
Comorbidity | 3 | 2017 | 10372 | 0.100 |
Why?
|
Endometrium | 1 | 1994 | 424 | 0.100 |
Why?
|
Sulfones | 2 | 2004 | 437 | 0.100 |
Why?
|
Hyponatremia | 1 | 1994 | 298 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15056 | 0.090 |
Why?
|
Survival Rate | 3 | 2015 | 12773 | 0.090 |
Why?
|
Fecal Impaction | 1 | 1990 | 34 | 0.090 |
Why?
|
Gender Identity | 1 | 2016 | 681 | 0.090 |
Why?
|
Purines | 2 | 2004 | 593 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2014 | 12017 | 0.090 |
Why?
|
Societies, Medical | 2 | 2019 | 3740 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2017 | 39004 | 0.090 |
Why?
|
World Health Organization | 1 | 1995 | 1317 | 0.090 |
Why?
|
Anemia | 1 | 2019 | 1499 | 0.090 |
Why?
|
Drug Therapy | 1 | 2013 | 497 | 0.090 |
Why?
|
Baltimore | 1 | 2010 | 231 | 0.090 |
Why?
|
Prevalence | 5 | 2015 | 15194 | 0.090 |
Why?
|
PubMed | 1 | 2009 | 122 | 0.090 |
Why?
|
Ureteral Calculi | 1 | 1990 | 110 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 1968 | 0.080 |
Why?
|
Journal Impact Factor | 1 | 2009 | 156 | 0.080 |
Why?
|
Recurrence | 2 | 2017 | 8333 | 0.080 |
Why?
|
Biopsy, Needle | 2 | 2008 | 1640 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10943 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2017 | 9941 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 1995 | 1385 | 0.080 |
Why?
|
Endocrine System Diseases | 1 | 2010 | 248 | 0.080 |
Why?
|
Fertilization in Vitro | 1 | 1995 | 1284 | 0.080 |
Why?
|
Administration, Cutaneous | 1 | 2010 | 711 | 0.080 |
Why?
|
Young Adult | 5 | 2019 | 56350 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 1995 | 2126 | 0.080 |
Why?
|
Age Distribution | 2 | 2004 | 2900 | 0.070 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 282 | 0.070 |
Why?
|
DNA Fragmentation | 2 | 1998 | 242 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2014 | 1359 | 0.070 |
Why?
|
Injections | 1 | 2010 | 840 | 0.070 |
Why?
|
Chemistry, Clinical | 1 | 2006 | 64 | 0.070 |
Why?
|
Likelihood Functions | 1 | 2010 | 1003 | 0.070 |
Why?
|
Flushing | 1 | 2006 | 49 | 0.070 |
Why?
|
Self Report | 1 | 2017 | 3548 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3528 | 0.070 |
Why?
|
Proteins | 2 | 1992 | 6096 | 0.070 |
Why?
|
Delayed-Action Preparations | 1 | 2010 | 965 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2203 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2014 | 13921 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1636 | 0.060 |
Why?
|
Dyspepsia | 1 | 2006 | 114 | 0.060 |
Why?
|
Vena Cava, Inferior | 1 | 1988 | 436 | 0.060 |
Why?
|
Dogs | 1 | 2010 | 3910 | 0.060 |
Why?
|
Mice, Inbred Strains | 2 | 1998 | 1827 | 0.060 |
Why?
|
Obesity | 3 | 2017 | 12705 | 0.060 |
Why?
|
Patient Selection | 2 | 2014 | 4214 | 0.060 |
Why?
|
Cohort Studies | 2 | 2019 | 40450 | 0.060 |
Why?
|
Stents | 2 | 1993 | 3276 | 0.060 |
Why?
|
Empty Sella Syndrome | 1 | 2003 | 14 | 0.060 |
Why?
|
Osteoporosis | 1 | 2013 | 1581 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2011 | 12958 | 0.060 |
Why?
|
Prostatic Diseases | 1 | 2004 | 56 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2015 | 3861 | 0.060 |
Why?
|
Brain Neoplasms | 1 | 2005 | 8829 | 0.060 |
Why?
|
Estradiol | 3 | 2019 | 2021 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2009 | 11001 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4414 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6534 | 0.060 |
Why?
|
Cilia | 2 | 1998 | 463 | 0.060 |
Why?
|
Fertility | 1 | 2008 | 770 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3766 | 0.060 |
Why?
|
Carcinoma | 1 | 2015 | 2374 | 0.060 |
Why?
|
Evidence-Based Medicine | 4 | 2017 | 3611 | 0.060 |
Why?
|
Polycythemia | 1 | 2004 | 126 | 0.060 |
Why?
|
Reference Standards | 1 | 2006 | 1020 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1668 | 0.050 |
Why?
|
Incidence | 3 | 2013 | 20928 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2009 | 16665 | 0.050 |
Why?
|
Congresses as Topic | 1 | 2007 | 764 | 0.050 |
Why?
|
Sperm Motility | 2 | 1995 | 253 | 0.050 |
Why?
|
Back Pain | 1 | 2006 | 545 | 0.050 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2002 | 159 | 0.050 |
Why?
|
Postoperative Period | 2 | 2017 | 1839 | 0.050 |
Why?
|
Kidney Diseases | 2 | 1990 | 2145 | 0.050 |
Why?
|
Recovery of Function | 3 | 2017 | 2924 | 0.050 |
Why?
|
Heat Stress Disorders | 1 | 2002 | 50 | 0.050 |
Why?
|
Psychometrics | 1 | 2011 | 2999 | 0.050 |
Why?
|
Neoplastic Cells, Circulating | 1 | 1988 | 933 | 0.050 |
Why?
|
Obesity, Abdominal | 2 | 2017 | 361 | 0.050 |
Why?
|
Self Concept | 1 | 2007 | 1025 | 0.050 |
Why?
|
Demography | 1 | 2006 | 1650 | 0.050 |
Why?
|
Hemorrhage | 2 | 1990 | 3461 | 0.050 |
Why?
|
Cell Division | 1 | 2008 | 4564 | 0.050 |
Why?
|
International Cooperation | 2 | 2017 | 1421 | 0.050 |
Why?
|
Adolescent | 3 | 2019 | 85649 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2714 | 0.040 |
Why?
|
Sexual Behavior, Animal | 2 | 1979 | 113 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2003 | 1902 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12344 | 0.040 |
Why?
|
Logistic Models | 1 | 2014 | 13403 | 0.040 |
Why?
|
Child, Preschool | 1 | 2021 | 40955 | 0.040 |
Why?
|
Rhinitis | 1 | 2006 | 691 | 0.040 |
Why?
|
Vasovasostomy | 1 | 1998 | 6 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2706 | 0.040 |
Why?
|
Trichomonas Infections | 1 | 1998 | 43 | 0.040 |
Why?
|
Headache | 1 | 2006 | 1219 | 0.040 |
Why?
|
HIV-1 | 1 | 1996 | 6934 | 0.040 |
Why?
|
Trichomonas vaginalis | 1 | 1998 | 76 | 0.040 |
Why?
|
Seminiferous Tubules | 1 | 1997 | 26 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14720 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4742 | 0.040 |
Why?
|
Mice | 6 | 2002 | 81045 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1997 | 212 | 0.040 |
Why?
|
Cell Fractionation | 1 | 1997 | 252 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2009 | 2229 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1998 | 718 | 0.040 |
Why?
|
Tuberculosis, Male Genital | 1 | 1996 | 6 | 0.040 |
Why?
|
Prognosis | 2 | 2007 | 29010 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 35342 | 0.030 |
Why?
|
Female | 12 | 2021 | 379592 | 0.030 |
Why?
|
Pilot Projects | 1 | 2009 | 8297 | 0.030 |
Why?
|
Neoplasms | 1 | 2005 | 21596 | 0.030 |
Why?
|
Administration, Oral | 1 | 2003 | 3913 | 0.030 |
Why?
|
Ejaculation | 1 | 2015 | 58 | 0.030 |
Why?
|
Algorithms | 3 | 2011 | 13853 | 0.030 |
Why?
|
Urinary Sphincter, Artificial | 1 | 1995 | 24 | 0.030 |
Why?
|
Sperm Count | 1 | 1995 | 216 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8621 | 0.030 |
Why?
|
Hernia | 1 | 1995 | 71 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2003 | 1340 | 0.030 |
Why?
|
Leydig Cell Tumor | 1 | 1994 | 25 | 0.030 |
Why?
|
Culture Techniques | 1 | 1995 | 554 | 0.030 |
Why?
|
Cells | 1 | 1995 | 168 | 0.030 |
Why?
|
Mycobacterium | 1 | 1996 | 249 | 0.030 |
Why?
|
Rats | 2 | 2003 | 24265 | 0.030 |
Why?
|
Nucleosomes | 1 | 1997 | 493 | 0.030 |
Why?
|
Prospective Studies | 2 | 2015 | 53187 | 0.030 |
Why?
|
Semen | 1 | 1995 | 316 | 0.030 |
Why?
|
Genetic Testing | 1 | 2006 | 3439 | 0.030 |
Why?
|
Isoelectric Point | 1 | 1992 | 80 | 0.030 |
Why?
|
Endothelial Growth Factors | 1 | 1995 | 694 | 0.030 |
Why?
|
Body Weight | 1 | 2003 | 4664 | 0.030 |
Why?
|
Adenoma | 1 | 2003 | 2168 | 0.030 |
Why?
|
Isoelectric Focusing | 1 | 1992 | 181 | 0.030 |
Why?
|
Lipids | 1 | 2004 | 3302 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2002 | 21821 | 0.030 |
Why?
|
Lymphokines | 1 | 1995 | 949 | 0.030 |
Why?
|
Burkitt Lymphoma | 1 | 1994 | 328 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 1992 | 222 | 0.030 |
Why?
|
Papaverine | 1 | 1991 | 46 | 0.030 |
Why?
|
Yohimbine | 1 | 1991 | 62 | 0.030 |
Why?
|
Urethra | 1 | 1993 | 408 | 0.020 |
Why?
|
Women's Health | 1 | 2021 | 2034 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 1997 | 1969 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2015 | 634 | 0.020 |
Why?
|
Endothelium | 1 | 1993 | 778 | 0.020 |
Why?
|
Sexology | 1 | 2010 | 1 | 0.020 |
Why?
|
Chorionic Gonadotropin | 1 | 1992 | 474 | 0.020 |
Why?
|
Reperfusion | 1 | 1991 | 284 | 0.020 |
Why?
|
Thymus Gland | 1 | 1995 | 1264 | 0.020 |
Why?
|
Mucous Membrane | 1 | 1993 | 670 | 0.020 |
Why?
|
Lithotripsy, Laser | 1 | 1990 | 46 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2255 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1769 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1801 | 0.020 |
Why?
|
Blotting, Western | 1 | 1997 | 5180 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1459 | 0.020 |
Why?
|
Urinary Catheterization | 1 | 1990 | 201 | 0.020 |
Why?
|
Abdomen | 1 | 1995 | 1107 | 0.020 |
Why?
|
Spleen | 1 | 1995 | 2359 | 0.020 |
Why?
|
Age of Onset | 1 | 2015 | 3266 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2006 | 19862 | 0.020 |
Why?
|
Patient Care Team | 1 | 1999 | 2527 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1737 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 1676 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 3617 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2011 | 977 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2002 | 14554 | 0.020 |
Why?
|
Signal Transduction | 1 | 2009 | 23387 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 1997 | 11363 | 0.020 |
Why?
|
Pregnancy | 1 | 2008 | 29087 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 24913 | 0.020 |
Why?
|
Mortality | 1 | 2017 | 2857 | 0.020 |
Why?
|
Equipment Design | 1 | 1993 | 3582 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1185 | 0.020 |
Why?
|
Radiography | 1 | 1996 | 7010 | 0.020 |
Why?
|
Coitus | 1 | 2005 | 133 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1157 | 0.020 |
Why?
|
Focus Groups | 1 | 2009 | 1320 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1994 | 1377 | 0.020 |
Why?
|
Gene Expression | 1 | 1997 | 7790 | 0.010 |
Why?
|
Nephrectomy | 1 | 1990 | 1049 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1995 | 8300 | 0.010 |
Why?
|
Laser Therapy | 1 | 1990 | 1071 | 0.010 |
Why?
|
DNA | 1 | 1997 | 7289 | 0.010 |
Why?
|
Insurance, Health | 1 | 2015 | 2493 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2009 | 2536 | 0.010 |
Why?
|
Medicine | 1 | 2010 | 941 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12695 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7716 | 0.010 |
Why?
|
Anticoagulants | 1 | 2015 | 4595 | 0.010 |
Why?
|
Endoscopy | 1 | 1990 | 1774 | 0.010 |
Why?
|
Castration | 1 | 1979 | 158 | 0.010 |
Why?
|
Kidney | 1 | 1995 | 7167 | 0.010 |
Why?
|
Liver | 1 | 1995 | 7470 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 21719 | 0.010 |
Why?
|
Decision Making | 1 | 2011 | 3869 | 0.010 |
Why?
|
Hypothalamus | 2 | 1979 | 1063 | 0.010 |
Why?
|
Kidney Neoplasms | 2 | 1990 | 4229 | 0.010 |
Why?
|
Silicone Elastomers | 1 | 1995 | 84 | 0.010 |
Why?
|
Aggression | 1 | 1979 | 753 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 1995 | 772 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5724 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1995 | 1950 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 1990 | 20086 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 1995 | 538 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 11472 | 0.000 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 1995 | 3502 | 0.000 |
Why?
|
Angiography | 1 | 1989 | 1636 | 0.000 |
Why?
|
Diencephalon | 1 | 1979 | 56 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1995 | 13029 | 0.000 |
Why?
|
Septum Pellucidum | 1 | 1979 | 58 | 0.000 |
Why?
|
Telencephalon | 1 | 1979 | 143 | 0.000 |
Why?
|
Mesencephalon | 1 | 1979 | 327 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1995 | 12071 | 0.000 |
Why?
|
Ultrasonography | 1 | 1989 | 5978 | 0.000 |
Why?
|
Gonadal Steroid Hormones | 1 | 1979 | 711 | 0.000 |
Why?
|
Brain Stem | 1 | 1979 | 844 | 0.000 |
Why?
|
Carcinoma, Renal Cell | 1 | 1989 | 3123 | 0.000 |
Why?
|
Corpus Striatum | 1 | 1979 | 1220 | 0.000 |
Why?
|
Brain | 1 | 1979 | 26343 | 0.000 |
Why?
|
Amygdala | 1 | 1979 | 1305 | 0.000 |
Why?
|
Brain Mapping | 1 | 1979 | 6669 | 0.000 |
Why?
|